Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Liposarcoma, Myxoid × mirdametinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

NF1 1 Multiple Myeloma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

selinexor 1 seclidemstat 1 pazopanib 1 palbociclib 1 mirdametinib 1 Trabectedin 1 Topotecan 1 Radiotherapy 1 Proton Therapy 1 Ifosfamide 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06843967 2026-03-13

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡